← Snapshot 21

Orange Book snapshot 21: Products

Products page 98 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
4852A078775001STAVUDINECAPSULE;ORALCAPSULEORALSTAVUDINEMYLAN LABS LTD30MG[]2009-01-05Jan 5, 2009NoNoNoDISCNMYLAN LABORATORIES LTD257106987f23ed62b7a5948c007cbd419ff78345667b4695eae6fb8c227912d2
4853A078775002STAVUDINECAPSULE;ORALCAPSULEORALSTAVUDINEMYLAN LABS LTD40MG[]2009-01-05Jan 5, 2009NoNoNoDISCNMYLAN LABORATORIES LTD4e18f57829dd366de918280f77aec7891b6bd441ac358bf064b6a69a44ad0013
4854N021411001ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSTRATTERALILLY5MG[]2002-11-26Nov 26, 2002NoNoNoDISCNELI LILLY AND CO9001e9c20afc1591efc46e81906f72fa5863b4f4c02c07a981e30c95ef906f11
4855N021411002ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSTRATTERALILLY10MGAB["AB"]2002-11-26Nov 26, 2002NoYesNoRXELI LILLY AND CO113004ef0128f307c9b16e46149cb0d6a1144b2a73f87cfee01d95912de509c8
4856N021411003ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSTRATTERALILLY18MGAB["AB"]2002-11-26Nov 26, 2002NoYesNoRXELI LILLY AND CO00ca93deb326962363290aff1e0af5f4c26fa5484a3f6f6c3a31225b8ee6a44c
4857N021411004ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSTRATTERALILLY25MGAB["AB"]2002-11-26Nov 26, 2002NoYesNoRXELI LILLY AND CO672d7fbde9ca71e4710638853170998b107400a1d9bdfcc80818c4e3798d2b78
4858N021411005ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSTRATTERALILLY40MGAB["AB"]2002-11-26Nov 26, 2002NoYesNoRXELI LILLY AND COcba2bac59a07cd7846d6e9b03b68b4d19ee970b707420d2682a3f2021896d38e
4859N021411006ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSTRATTERALILLY60MGAB["AB"]2002-11-26Nov 26, 2002NoYesYesRXELI LILLY AND COcd31a0655e7249420c69bb23c4de8aeae760d481d4a84c8281afe86afadfcebc
4860N021411007ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSTRATTERALILLY80MGAB["AB"]2005-02-14Feb 14, 2005NoYesNoRXELI LILLY AND CO58cd252dc93156389bc9e5d84a3525507c8ab3033604c4abc5ea3ded3c684b0c
4861N021411008ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSTRATTERALILLY100MGAB["AB"]2005-02-14Feb 14, 2005NoYesNoRXELI LILLY AND CO606aabcb72be1e74d88113892b502e6641423b6af576ae090c1d3518b808c99d
4862A087666001SULFINPYRAZONECAPSULE;ORALCAPSULEORALSULFINPYRAZONEBARR200MG[]1982-09-17Sep 17, 1982NoNoNoDISCNBARR LABORATORIES INC5c2b1336ed0aaf29a2323413c536d1f3c416ddaaa5c7a6c0aeae8af24191d6f1
4863A087770001SULFINPYRAZONECAPSULE;ORALCAPSULEORALSULFINPYRAZONEIVAX PHARMS200MG[]1982-11-19Nov 19, 1982NoNoNoDISCNIVAX PHARMACEUTICALS INC185c24e4345b0cb918ad6b23cfa964d825d4b61c9ce578d073c16a78f37e0c43
4864A088934001SULFINPYRAZONECAPSULE;ORALCAPSULEORALSULFINPYRAZONEPAR PHARM200MG[]1985-09-06Sep 6, 1985NoNoNoDISCNPAR PHARMACEUTICAL INCf11d7bec586facff790d96e0227398e57bb7ccb677902af2a379665e5a14db71
4865A088666001SULFINPYRAZONECAPSULE;ORALCAPSULEORALSULFINPYRAZONEVANGARD200MG[]1984-02-17Feb 17, 1984NoNoNoDISCNVANGARD LABORATORIES INC DIV MIDWAY MEDICAL COc4f0e60312df536c619309bb7e13228a0a80c59be5309348554de49e92f1379d
4866A060429002TETRACYCLINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSUMYCINAPOTHECON100MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNAPOTHECON INC DIV BRISTOL MYERS SQUIBB84dc6f592c6331f04d6253f6cee3e9a90c32bd3d7a1799d48f19c97b64c12220
4867A060429004TETRACYCLINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSUMYCINAPOTHECON125MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNAPOTHECON INC DIV BRISTOL MYERS SQUIBB4fe3e8c1846a7d646bc7898b8cc2d2d36eb8f49dbf52932650ba2d23aa373baf
4868A060429001TETRACYCLINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSUMYCINAPOTHECON250MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNAPOTHECON INC DIV BRISTOL MYERS SQUIBB7259acec30243b65ffd8037657b1242190dbcb07314e26eadc8cd39ca9963811
4869A060429003TETRACYCLINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSUMYCINAPOTHECON500MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNAPOTHECON INC DIV BRISTOL MYERS SQUIBB508d0377792b6482ea6a78998028f9d20dfd7bf071f5f37981974c777a9e736f
4870N203195001CEFIXIMECAPSULE;ORALCAPSULEORALSUPRAXLUPIN LTD400MG[]2012-06-01Jun 1, 2012NoYesNoDISCNLUPIN LTD9e82e2f70b73e6a64cbf8e768dfda71ccc8c25eafbf621fbe233c2d9d94cb021
4871N016792001TRIMIPRAMINE MALEATECAPSULE;ORALCAPSULEORALSURMONTILODYSSEY PHARMSEQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNODYSSEY PHARMACEUTICALS INC18dda468c2ceaf96d41b144ccc63058eb71faaae7d695b40574b4b9cfbe891dc
4872N016792002TRIMIPRAMINE MALEATECAPSULE;ORALCAPSULEORALSURMONTILODYSSEY PHARMSEQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNODYSSEY PHARMACEUTICALS INC0d18fd40d92233d73461a61e50b85e4aec43aead6cd5552e22658496587f83d6
4873N016792003TRIMIPRAMINE MALEATECAPSULE;ORALCAPSULEORALSURMONTILODYSSEY PHARMSEQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1982-09-15Sep 15, 1982NoYesNoDISCNODYSSEY PHARMACEUTICALS INC4ab2cebaf5bf0ebec42b58c4848a722d6799f6cd8643bbe78c015c161c0b0c62
4874N020972001EFAVIRENZCAPSULE;ORALCAPSULEORALSUSTIVABRISTOL MYERS SQUIBB50MGAB["AB"]1998-09-17Sep 17, 1998NoYesNoRXBRISTOL MYERS SQUIBB CO6b1e04773705ffb1d32962551618836724cbe7bdc6af7c39dd0cc1dfbff2f5b4
4875N020972002EFAVIRENZCAPSULE;ORALCAPSULEORALSUSTIVABRISTOL MYERS SQUIBB100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1998-09-17Sep 17, 1998NoYesNoDISCNBRISTOL MYERS SQUIBB COcb465f9f859ba7f628a3ccf3702f8e92f22613bd9a3dcaaed924b0d705b47521
4876N020972003EFAVIRENZCAPSULE;ORALCAPSULEORALSUSTIVABRISTOL MYERS SQUIBB200MGAB["AB"]1998-09-17Sep 17, 1998NoYesYesRXBRISTOL MYERS SQUIBB COfce301be88f1d2d5bef3dd7c96becab1a9d3526553a89d8befacf635d1905d88
4877N021938001SUNITINIB MALATECAPSULE;ORALCAPSULEORALSUTENTCPPI CVEQ 12.5MG BASE[]2006-01-26Jan 26, 2006NoYesNoRXCP PHARMACEUTICALS INTERNATIONAL CVe0f5b334c1badb72d5ac65963999a14a63efd9f4cd50027edfef6d24deb7870e
4878N021938002SUNITINIB MALATECAPSULE;ORALCAPSULEORALSUTENTCPPI CVEQ 25MG BASE[]2006-01-26Jan 26, 2006NoYesNoRXCP PHARMACEUTICALS INTERNATIONAL CV0683980ea5e723edcd87c1b8f519ca922341d156abb5a374fc412168fc309a12
4879N021938004SUNITINIB MALATECAPSULE;ORALCAPSULEORALSUTENTCPPI CVEQ 37.5MG BASE[]2009-03-31Mar 31, 2009NoYesNoRXCP PHARMACEUTICALS INTERNATIONAL CV940fd53b511ccd8062c97c4cc70277c5f5aef71f40e393e844110ea5c0bc52bb
4880N021938003SUNITINIB MALATECAPSULE;ORALCAPSULEORALSUTENTCPPI CVEQ 50MG BASE[]2006-01-26Jan 26, 2006NoYesYesRXCP PHARMACEUTICALS INTERNATIONAL CV001542fe9d2c0065334370059bbe0d1fa51630df309b8efc7a270ca79353a0a2
4881A071000001AMANTADINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSYMADINESOLVAY100MG[]1986-09-04Sep 4, 1986NoNoNoDISCNSOLVAY PHARMACEUTICALSc9666f5a00c9523ec913959d268f0474cef22d026adaa1a4cb28313d88cbd996
4882N021520001FLUOXETINE HYDROCHLORIDE; OLANZAPINECAPSULE;ORALCAPSULEORALSYMBYAXLILLYEQ 25MG BASE;EQ 3MG BASEAB["AB"]2007-04-09Apr 9, 2007NoYesNoRXELI LILLY AND CO72c7859052a71b82ad28c385ac05999282e6df97aa756f443c310d26733de537
4883N021520002FLUOXETINE HYDROCHLORIDE; OLANZAPINECAPSULE;ORALCAPSULEORALSYMBYAXLILLYEQ 25MG BASE;EQ 6MG BASEAB["AB"]2003-12-24Dec 24, 2003NoYesNoRXELI LILLY AND CO67011487c78e45fb1148fa0ad300b92822c7e9f4cc1a1a1e9a03f5edd98c3228
4884N021520004FLUOXETINE HYDROCHLORIDE; OLANZAPINECAPSULE;ORALCAPSULEORALSYMBYAXLILLYEQ 25MG BASE;EQ 12MG BASEAB["AB"]2003-12-24Dec 24, 2003NoYesNoRXELI LILLY AND CO0e0769a42f6bcc07d8f47796b37f04268c7eeb3b0838f8ae9cf69ae6ba55b570
4885N021520003FLUOXETINE HYDROCHLORIDE; OLANZAPINECAPSULE;ORALCAPSULEORALSYMBYAXLILLYEQ 50MG BASE;EQ 6MG BASEAB["AB"]2003-12-24Dec 24, 2003NoYesYesRXELI LILLY AND CO393383ee41d8a92136dfbfcc4a4a600648814dccbb7bf4e30e00e5d4f5dc3ad8
4886N021520005FLUOXETINE HYDROCHLORIDE; OLANZAPINECAPSULE;ORALCAPSULEORALSYMBYAXLILLYEQ 50MG BASE;EQ 12MG BASEAB["AB"]2003-12-24Dec 24, 2003NoYesNoRXELI LILLY AND CO0b5063e5da19d72d518c6bdfee66de5c76eeb98084d2c6e9d3d08da1fd03fe7a
4887N016020001AMANTADINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSYMMETRELENDO PHARMS100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNENDO PHARMACEUTICALS INCa9870647fcf19d05824099d529cde41662cc6337a192a1ea853a4b2469b1a8f6
4888N011483004ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATECAPSULE;ORALCAPSULEORALSYNALGOS-DCSUN PHARM INDUSTRIES356.4MG;30MG;16MG[]1983-09-06Sep 6, 1983NoYesNoDISCNSUN PHARMACEUTICAL INDUSTRIES INC23178b120a7dbf089620ce774ee2fc3be17d7de369f911ab8c0709a6f54c8cbc
4889A089166001ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATECAPSULE;ORALCAPSULEORALSYNALGOS-DC-ALEITNER PHARMS356.4MG;30MG;16MG[]1986-05-14May 14, 1986NoNoNoDISCNLEITNER PHARMACEUTICALS LLCd5e2e717777cc124c734f07c0228a30bcc7d9743beb9ce5222f19956ee46fe47
4890N019194001TRIENTINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALSYPRINEBAUSCH250MGAB["AB"]1985-11-08Nov 8, 1985NoYesYesRXBAUSCH HEALTH AMERICAS INC143a51439cbff39e719411a14da4886e06496397d6db30abd9a89e7355882506
4891N008102004CHLOROTRIANISENECAPSULE;ORALCAPSULEORALTACESANOFI AVENTIS US12MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNSANOFI AVENTIS US LLCed1988729324562574dcb8122a63e77249ed1822d8f9331b155af4a694813415
4892N011444001CHLOROTRIANISENECAPSULE;ORALCAPSULEORALTACESANOFI AVENTIS US25MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNSANOFI AVENTIS US LLC5da550b44b0287142e61006936d419e788b455005b64c47875e09844979fb486
4893N016235001CHLOROTRIANISENECAPSULE;ORALCAPSULEORALTACESANOFI AVENTIS US72MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNSANOFI AVENTIS US LLC8ae6414f0093f1471bd63691412f45c094e5664e2a62deefb0046fe29c8be5c6
4894A091195001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSACCORD HLTHCAREEQ 0.5MG BASEAB["AB"]2011-08-31Aug 31, 2011NoNoNoRXACCORD HEALTHCARE INC58ce9e67c977d157319a754f78c65c8882f57469d8f47e084730050d165240f4
4895A091195002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSACCORD HLTHCAREEQ 1MG BASEAB["AB"]2011-08-31Aug 31, 2011NoNoNoRXACCORD HEALTHCARE INC5a56b1decd8cd5a9de298f6481cdc9987e975e949d52b2f24f04a53d20b8fd6d
4896A091195003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSACCORD HLTHCAREEQ 5MG BASEAB["AB"]2011-08-31Aug 31, 2011NoNoNoRXACCORD HEALTHCARE INC0b25444a7785d63d353ab83ac07bb294fcad0656b2e9b4df34b09695eb17de86
4897A203740001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSALKEM LABS LTDEQ 0.5MG BASEAB["AB"]2020-11-12Nov 12, 2020NoNoNoRXALKEM LABORATORIES LTD22c07355c1a93cc2eb6a7618fe212626e83df570206386901bb9e8a6c8e9b5ad
4898A203740002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSALKEM LABS LTDEQ 1MG BASEAB["AB"]2020-11-12Nov 12, 2020NoNoNoRXALKEM LABORATORIES LTD29c7d782bae2e7d925fe09d02f70c69c26d693a5dc09b5d6a86136de16737755
4899A203740003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSALKEM LABS LTDEQ 5MG BASEAB["AB"]2020-11-12Nov 12, 2020NoNoNoRXALKEM LABORATORIES LTD993339485c4f4c788c758e7c10f7d9403307de68a680d83fe5a3fb575d6efeb1
4900A206651001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSBELCHEREQ 0.5MG BASEAB["AB"]2017-11-30Nov 30, 2017NoNoNoRXBELCHER PHARMACEUTICALS LLC6e134d493db2cd205c4723df75aaad176bc9b5493b7efec1328e15999fea69fe
4901A206651002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSBELCHEREQ 1MG BASEAB["AB"]2017-11-30Nov 30, 2017NoNoNoRXBELCHER PHARMACEUTICALS LLC0360bada92708069419257289c5ecc730edefc7c434ad8ccf74662027dd3aec7